YKHC Low-Risk Endoscopy Criteria: Difference between revisions
No edit summary |
No edit summary |
||
Line 31: | Line 31: | ||
# No use of anti-arrythmic drugs within 12 months | # No use of anti-arrythmic drugs within 12 months | ||
# Meets all of the "CHF" criteria above | # Meets all of the "CHF" criteria above | ||
==PULMONARY== | ==PULMONARY== | ||
===COPD=== | ===COPD=== | ||
* Post-bronchodilator FEV<sub>1</sub> >= 60% of predicted | * Post-bronchodilator FEV<sub>1</sub> >= 60% of predicted | ||
** order as "PFT(Pre-&Post-Albuterol)Eval" | |||
===OSA=== | ===OSA=== |
Revision as of 20:55, 11 October 2017
OVERVIEW
Because YKHC has no ICU, serious endoscopy complications require transfer to the Emergency Department and/or Medevac transfer. Prevention of this occurrence is a priority. Therefore endoscopy in Bethel is limited to low risk patients.
The intention of this page is to provide transparent criteria for the most common conditions which increase the risk of an endoscopy complication. This page is not all-inclusive.
These criteria are written with isolated diagnoses in mind. The presence of multiple comorbidities may yield a higher risk than either individually and this effect is not incorporated into these criteria.
The intention of these criteria is to risk stratify based on the functional status of a disease rather than its mere mention in a patient's chart.
GENERAL
BMI
- BMI < 45 (non-negotiable limit)
- For BMI 40-45, consult anesthesia PRIOR TO ORDERING; the decision will likely hinge upon the absence or presence of comorbidities.
CARDIAC
CHF
- Most recent LVEF >= 40%
- Recent (<6mos) BNP <= 125 pg/mL (or YKHC laboratory’s current upper limit of normal)
- No loop diuretic use (chronic or acute) within the last 12 months
CAD
- No history of coronary revascularization (either surgical or endovascular)
- No use of anti-angina agents in the last 12 months
- Normal cardiac stress test within the last 12 months
A-Fib
- Currently in sinus rythm
- No subjective or objective A-Fib occurrence within 12 months
- No use of anti-arrythmic drugs within 12 months
- Meets all of the "CHF" criteria above
PULMONARY
COPD
- Post-bronchodilator FEV1 >= 60% of predicted
- order as "PFT(Pre-&Post-Albuterol)Eval"
OSA
- Positive pressure ventilation has NOT been recommended/prescribed
- Anesthesia consult approval
MEDICATIONS
Antiplatelets
- _
Anticoagulants
- _
Opioid Replacement Therapy
- _